A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 65,476 shares of PTCT stock, worth $3.03 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
65,476
Previous 59,698 9.68%
Holding current value
$3.03 Million
Previous $1.83 Million 33.1%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.39 - $37.66 $175,593 - $217,599
5,778 Added 9.68%
65,476 $2.43 Million
Q2 2024

Aug 14, 2024

BUY
$24.69 - $40.12 $1.47 Million - $2.4 Million
59,698 New
59,698 $1.83 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.